UPDATE: Morgan Stanley Reiterates On Genpact Limited Following Solid 1Q14 Results
In a report published Tuesday, Morgan Stanley analyst Vipin Khare reiterated an Equal-Weight rating on Genpact Limited (NYSE: G), but removed the $18.00 price target.
In the report, Morgan Stanley noted, “Genpact reported stronger-than-expected revenues and margins in 1Q. The GE account declined less than guided (-3%yoy). However, net income was in line with expectations. Overall, lack of guidance revisions and EPS upside leaves limited near-term triggers, in our view. Maintain EW.”
Genpact Limited closed on Monday at $16.95.
Latest Ratings for G
|Apr 2014||Morgan Stanley||Resumes||Equal-weight|
|Feb 2014||Morgan Stanley||Maintains||Overweight|
|Feb 2014||Global Hunter||Initiates Coverage on|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.